查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1985974

美國乳房切片設備市場：市場規模、佔有率和趨勢分析（按產品類型、手術類型、引導技術、最終用途和地區分類），細分市場預測（2026-2033 年）

U.S. Breast Biopsy Devices Market Size, Share & Trends Analysis Report By Product Type, By Procedure Type, By Guidance Technology, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國乳房切片設備市場概述

據估計，2025 年美國乳房切片設備市場價值為 11.8 億美元，預計到 2033 年將達到 16 億美元，2026 年至 2033 年的複合年成長率為 3.9%。

乳癌發生率的上升以及由此導致的對早期發現和準確診斷的重視，推動了市場成長，進而增加了篩檢和診斷過程中所需的切片檢查次數。

患者和臨床醫生對該設備的高度認知，加上系統性的篩檢計畫和有利的保險報銷政策，進一步推動了該設備的普及。此外，微創穿刺粗針切片、真空輔助系統、與先進影像技術（超音波、磁振造影、3D乳房X光攝影等）的整合以及人工智慧驅動的診斷工作流程等技術進步，正在拓展該設備的臨床效用，提高手術精準度和患者舒適度，並促進更廣泛的臨床應用。

美國乳癌發生率的上升直接推動了乳房切片設備市場的成長。這是因為不斷增加的新發和疑似癌症病例促使人們對活體組織切片進行診斷以確診。在美國，乳癌是女性最常見的癌症，每年報告的新增侵襲性和非侵襲性病例達數十萬例。這導致常規篩檢和影像檢查檢查發現異常時進行的後續切片檢查數量增加。隨著發病率的上升和篩檢項目的擴大，醫療專業人員進行更多切片檢查以確診、制定治療方案並排除惡性腫瘤，從而導致空芯針穿刺活體組織切片、真空輔助切片檢查和影像引導乳房切片設備的使用量增加。

隨著乳房X光檢查和磁振造影（MRI）等篩檢計畫的推廣，越來越多的可疑病變被發現，因此需要透過空芯針穿刺活體組織切片和真空輔助切片檢查進行組織取樣。診斷數量的持續成長推動了醫院和門診對先進影像導引切片檢查系統的需求。近期行業趨勢表明，病例檢出率的提高與設備創新之間存在著密切的關聯。例如，2026年2月，丹納赫公司（Danaher Corporation）旗下子公司Mammotome發布了Mammotome Prima MR雙真空輔助乳房活體組織切片系統，這是首個設計用於在MRI掃描室切片檢查過程中放置於患者身旁的系統。這些創新透過提升醫護人員在MRI引導手術中的協作效率和工作流程效率，有效緩解了乳癌發病率上升帶來的日益繁重的手術負擔，從而加速了美國乳房切片設備產業的技術應用和整體市場成長。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：美國乳房切片設備市場：影響因素、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 美國乳房切片設備市場：分析工具
    • 波特五力分析
    • PESTEL 分析

第4章：美國乳房切片設備市場：按產品分類的估算與趨勢分析

  • 美國乳房切片設備市場：按產品分類的波動分析（2025-2033 年）
  • 美國乳房切片器材市場：市場規模與趨勢分析：按產品分類（2021-2033 年）
    • 切片檢查引導系統
    • 切片檢查驅動器/牙科手機
    • 切片檢查台
    • 切片檢查耗材
    • 其他消耗品

第5章：美國乳房切片設備市場：依手術類型分類的估算與趨勢分析

  • 美國乳房切片器械市場：按手術類型分類的波動分析（2025-2033 年）
  • 美國乳房切片器械市場：市場規模和趨勢分析：按手術類型分類（2021-2033 年）
    • 真空輔助切片檢查（VAB）
    • 核心針穿刺切片（CNB）
    • 細針穿刺切片檢查（FNAB）
    • 手術（開放式）切片檢查
    • 液態生物檢體

第6章：美國乳房切片設備市場：領先技術的估算與趨勢分析

  • 美國乳房切片設備市場：依感應技術分類的波動分析（2025-2033 年）
  • 美國乳房切片設備市場：市場規模與趨勢分析：按領先技術分類（2021-2033 年）
    • 在超音波引導下
    • 乳房X光攝影/立體定向
    • 磁共振引導

第7章：美國乳房切片設備市場：依最終用途分類的估算與趨勢分析

  • 美國乳房切片設備市場：按最終用途分類的波動分析（2025-2033 年）
  • 美國乳房切片設備市場：市場規模和趨勢分析：按最終用途分類（2021-2033 年）
    • 醫院
    • 門診手術中心（ASC）
    • 乳房護理專科中心
    • 診斷中心/影像診斷中心

第8章 競爭情勢

  • 近期趨勢及影響分析：依主要市場參與企業
  • 公司分類
  • 企業市場占有率分析（2025 年）
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 研究與開發
    • 公司簡介
    • Hologic, Inc.
    • Mammotome (Danaher)
    • BD
    • Argon Medical
    • Merit Medical Systems
    • GE HealthCare
    • Cook Medical
    • MOLLI Surgical (Stryker)
    • Planmed Oy
    • Siemens Healthineers
    • Fujifilm Healthcare
    • INRAD
    • Resitu Medical
    • TransMed7, LLC.
Product Code: GVR-4-68040-865-5

U.S. Breast Biopsy Devices Market Summary

The U.S. breast biopsy devices market size was estimated at USD 1.18 billion in 2025 and is anticipated to reach USD 1.60 billion by 2033, growing at a CAGR of 3.9% from 2026 to 2033. The market growth driven by the rising incidence of breast cancer and the consequent emphasis on early detection and accurate diagnosis, which increases the volume of biopsy procedures required in screening and diagnostic pathways.

High awareness among patients and clinicians, supported by structured screening programs and favorable reimbursement landscapes, further propels device adoption. In addition, technological advancements, including minimally invasive core-needle and vacuum-assisted systems, integration with advanced imaging modalities (e.g., ultrasound, MRI, 3D mammography), and AI-enhanced diagnostic workflows, are expanding clinical utility, improving procedural accuracy and patient comfort, and encouraging broader clinical integration.

The rising prevalence of breast cancer in the U.S. directly drives growth in the breast biopsy devices market because a higher number of new and suspected cancer cases increases the demand for diagnostic confirmation through tissue sampling. In the U.S., breast cancer is the most commonly diagnosed cancer among women, with hundreds of thousands of new invasive and non-invasive cases reported annually, prompting more routine screening and follow-up biopsies when abnormalities are detected on imaging. As incidence rates climb and screening programs expand, healthcare providers perform more biopsies to confirm diagnoses, guide treatment decisions, and rule out malignancy, thereby boosting utilization of core-needle, vacuum-assisted, and image-guided breast biopsy devices.

As screening programs such as mammography and MRI expand, more suspicious lesions are detected, necessitating tissue sampling via core-needle or vacuum-assisted biopsy. This sustained rise in diagnostic volumes increases demand for advanced, image-guided biopsy systems in hospitals and ambulatory centers. The link between higher case detection and device innovation is evident in recent industry developments, for instance, in February 2026, Mammotome, a part of Danaher Corporation, introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the first system designed to be positioned inside the MRI scanner room at the patient's side during biopsy. By improving clinician coordination and workflow efficiency in MRI-guided procedures, such innovations address the growing procedural burden driven by rising breast cancer prevalence, thereby accelerating technology adoption and overall market growth in the U.S. breast biopsy devices sector.

U.S. Breast Biopsy Devices Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. breast biopsy devices market report based on product, procedure type, guidance technology, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopsy Guidance Systems
    • Biopsy Drivers & Handpieces
    • Vacuum-Assisted Biopsy (VAB) Drivers
  • Core Needle Biopsy (CNB) Guns
    • Automated
    • Semi-Automated
  • Biopsy Tables
    • Prone Tables
    • Upright/Add-on Tables
  • Biopsy Consumables
    • Needles & Probes
    • Site Markers & Clips
    • By Shape/Design
    • Standard Geometric Markers
    • Ring
    • Cross
    • Ribbon
    • Others
    • Advanced Anchoring Markers
    • Anchor
    • Wing, "U" Shape
    • Q" Shape
    • 3D / Expandable Markers
    • 3D Ribbon
    • 3D Sphere
    • 3D Mesh
    • Localization Systems
    • Traditional Wires
    • Wireless Seeds-RFID/Magnetic
  • Other Consumables
  • Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Vacuum-Assisted Biopsy (VAB)
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration Biopsy (FNAB)
  • Surgical (Open) Biopsy
  • Liquid Biopsy
  • Guidance Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ultrasound-Guided
  • Mammography / Stereotactic-Guided
  • MRI-Guided
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Breast Care Centers
  • Diagnostic Centers/Imaging Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Procedure Type
    • 1.1.3. Guidance Technology
    • 1.1.4. End Use
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Biopsy Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing burden of breast cancer
      • 3.2.1.2. Expansion of breast cancer screening programs
      • 3.2.1.3. Technological advancements in imaging-guided biopsy
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced biopsy technologies
      • 3.2.2.2. Limited access to diagnostic facilities in low-resource settings
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of screening programs in emerging economies
      • 3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
      • 3.2.3.3. Integration with next-generation imaging and AI
      • 3.2.3.4. Expansion of outpatient and ambulatory care
      • 3.2.3.5. Rising demand for personalized and precision diagnostics
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Patient anxiety and procedure hesitation
      • 3.2.4.2. Limited skilled workforce
  • 3.3. U.S. Breast Biopsy Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. U.S. Breast Biopsy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Biopsy Guidance Systems
      • 4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Biopsy Drivers & Handpieces
      • 4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
        • 4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Core needle biopsy (CNB) guns
        • 4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.2. Automated
          • 4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.3. Semi-automated
          • 4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Biopsy tables
      • 4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Prone tables
        • 4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Upright/add-on tables
        • 4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Biopsy consumables
      • 4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.2. Needles & probes
        • 4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3. Site markers & clips
        • 4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.2. By shape/design
          • 4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3. Standard geometric markers
          • 4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.2. Ring
            • 4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.3. Cross
            • 4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.4. Ribbon
            • 4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.5. Others
            • 4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4. Advanced anchoring markers
          • 4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.2. Anchor
            • 4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.3. Wing, "U" shape
            • 4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.4. "Q" shape
            • 4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5. 3D / expandable markers
          • 4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.2. 3D ribbon
            • 4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.3. 3D sphere
            • 4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.4. 3D Mesh
            • 4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.4. Localization systems
        • 4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.2. Traditional wires
          • 4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.3. Wireless Seeds-RFID/magnetic
          • 4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Other Consumables
      • 4.3.5.1. Other consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Biopsy Devices Market: Procedure Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Biopsy Devices Market: Procedure Type Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Procedure Type, 2021 to 2033 (USD Million)
    • 5.3.1. Vacuum-Assisted Biopsy (VAB)
      • 5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Core Needle Biopsy (CNB)
      • 5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Fine Needle Aspiration Biopsy (FNAB)
      • 5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Surgical (Open) Biopsy
      • 5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Liquid Biopsy
      • 5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
    • 6.3.1. Ultrasound-Guided
      • 6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Mammography / Stereotactic-Guided
      • 6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. MRI-Guided
      • 6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals
      • 7.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Ambulatory Surgical Centers (ASCs)
      • 7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Specialized Breast Care Centers
      • 7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Diagnostic Centers/Imaging Centers
      • 7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Hologic, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Mammotome (Danaher)
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. BD
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Argon Medical
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Merit Medical Systems
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. GE HealthCare
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Cook Medical
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. MOLLI Surgical (Stryker)
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Planmed Oy
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Siemens Healthineers
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Fujifilm Healthcare
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. INRAD
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Resitu Medical
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. TransMed7, LLC.
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 U.S. breast biopsy devices market, by product type 2021 - 2033 (USD Million)
  • Table 3 U.S. breast biopsy devices market, by procedure type 2021 - 2033 (USD Million)
  • Table 4 U.S. breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 5 U.S. breast biopsy devices market, by end use 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. breast biopsy devices market segmentation.
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing.
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot.
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 U.S. breast biopsy devices - market size and growth prospects (USD Million)
  • Fig. 11 U.S. breast biopsy devices market: Industry Value Chain Analysis
  • Fig. 12 U.S. breast biopsy devices market: Market Dynamics
  • Fig. 13 U.S. breast biopsy devices market: PORTER's Analysis
  • Fig. 14 U.S. breast biopsy devices market: PESTEL Analysis
  • Fig. 15 U.S. breast biopsy devices market share by product type, 2025 & 2033 (USD Million)
  • Fig. 16 Breast biopsy devices market, by product type: market share, 2025 & 2033.
  • Fig. 17 Biopsy guidance systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Biopsy drivers & handpieces market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Vacuum-assisted biopsy (VAB) drivers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Core needle biopsy (CNB) guns market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Automated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Semi-automated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Biopsy tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Prone tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Upright/add-on tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 26 Biopsy consumables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Needles & probes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Site markers & clips market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 By shape/design market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Standard geometric markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 31 Ring market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 32 Cross market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 33 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Advanced anchoring markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 35 Anchor market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Wing, "U" shape market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 "Q" shape market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 3D / expandable markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 39 3D ribbon market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 40 3D sphere market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 41 3D mesh market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 42 Localization systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 43 Traditional wires market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 44 Wireless seeds-RFID/magnetic market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 45 Other consumables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 46 U.S. breast biopsy devices market share by procedure type, 2025 & 2033 (USD Million)
  • Fig. 47 U.S. breast biopsy devices market, by procedure type: market share, 2025 & 2033.
  • Fig. 48 Vacuum-assisted biopsy (VAB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 49 Core needle biopsy (CNB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 50 Fine needle aspiration biopsy (FNAB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 51 Surgical (open) biopsy market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 52 Liquid biopsy market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 53 U.S. breast biopsy devices market share by guidance technology, 2025 & 2033 (USD Million)
  • Fig. 54 U.S. breast biopsy devices market, by guidance technology: market share, 2025 & 2033.
  • Fig. 55 Ultrasound-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 56 Mammography / stereotactic-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 57 MRI-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 58 U.S. breast biopsy devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 59 U.S. breast biopsy devices market, by end use: market share, 2025 & 2033.
  • Fig. 60 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 61 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 62 Specialized breast care centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 63 Diagnostic centers/imaging centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 64 Key company categorization
  • Fig. 65 Company market positioning
  • Fig. 66 Key company market share analysis, 2025
  • Fig. 67 Strategic framework